Related Experiment Video
Updated: Jul 10, 2026
06:32
Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells
Published on: September 1, 2010
Developmental signaling pathways in brain tumor-derived stem-like cells.
Paul A Clark1, Daniel M Treisman, Johnathan Ebben
1Brain Tumor Research Lab, Department of Neurological Surgery, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin 53792-8660, USA.
Summary
Brain tumor-initiating cells share stem-like properties with neural stem cells. Targeting developmental pathways in these brain tumor stem cells (BTSCs) offers novel therapeutic potential.
Area of Science:
- Neuro-oncology
- Developmental Biology
- Cancer Stem Cell Biology
Background:
- Brain tumors contain a subpopulation of cells with stem-like properties, termed brain tumor stem-like cells (BTSCs).
- BTSCs exhibit self-renewal, proliferation, and multipotency, resembling normal neural stem cells (NSCs).
- Aberrant activation of developmental pathways (WNT, Hedgehog, Notch, TGF-β/BMP) is implicated in brain tumor development.
Purpose of the Study:
- To review the role of developmental pathways in brain tumors.
- To explore the potential of targeting these pathways for novel biological therapies against BTSCs.
- To analyze the impact of pathway regulation on BTSC-driven tumorigenesis.
Main Methods:
- Literature review of studies on brain tumor stem cells and developmental pathways.
- Analysis of aberrant signaling in brain tumors and normal neural stem cells.
- Discussion of therapeutic strategies targeting BTSCs.
Main Results:
- Developmental pathways are dysregulated in brain tumors, contributing to BTSC characteristics.
- These pathways are crucial for both normal neural development and tumor initiation/growth.
- Targeting these pathways presents a promising avenue for brain tumor treatment.
Conclusions:
- Understanding and regulating multiple cellular mechanisms is essential for effective therapeutic strategies.
- Inhibiting BTSC growth while minimizing effects on normal neural stem cells requires a nuanced approach.
- Developmental pathway modulation holds significant potential for future brain tumor therapies.
Related Concept Videos
01:19Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
02:40Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
02:40Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
03:14Notch Signaling Pathway
The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...